Format

Send to

Choose Destination
Vaccine. 2006 Jan 9;24(1):36-44. Epub 2005 Aug 2.

Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.

Author information

1
Molecular Microbiology Group, Division of Infection, Inflammation and Repair, University of Southampton Medical School, Southampton General Hospital, Mailpoint 814, Level C, Lab and Path Block, Tremona Road, Southampton SO16 6YD, UK.

Abstract

Four serosubtypes (P1.7, 16, P1.7-2, 4, P1.19, 15 and P1.5-1, 10-4) of the PorA outer-membrane protein of Neisseria meningitidis were purified as recombinant proteins and incorporated into liposomes to investigate their immunogenicity. Each serosubtype induced high levels of bactericidal activity against the homologous strain. In addition, liposome preparations containing multiple serosubtypes induced high levels of bactericidal activity against each of the four strains. Significantly, antisera raised against monovalent and multivalent liposomes also showed cross-reactive bactericidal activity against heterologous strains. These data demonstrate that multivalent liposome vaccines, containing multiple PorA serosubtypes, have the potential to provide protection against a broad range of meningococcal strains.

PMID:
16105711
DOI:
10.1016/j.vaccine.2005.07.056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center